How Is Soy Genetically Modified? The Process Explained

Most genetically modified (GM) soybean on the market today got its foreign DNA through one of two laboratory methods: infection by a soil bacterium called Agrobacterium that naturally transfers DNA into plant cells, or physical bombardment of plant tissue with microscopic DNA-coated particles. Both routes achieve the same basic goal of inserting a new gene into the soybean genome, but they work in very different ways and each has trade-offs in precision, speed, and the kinds of tissue they work best with. The process from initial DNA delivery to a field-ready seed involves several distinct stages, and understanding each one clarifies what “genetically modified soy” actually means at a molecular level.

Getting Foreign DNA Into a Soybean Cell

The first challenge is persuading a soybean cell to take up a piece of DNA it would never encounter in nature. Two delivery methods dominate the field. The older and still widely used approach relies on Agrobacterium tumefaciens, a bacterium that evolved to insert its own DNA into plant wounds. Scientists replace the bacterium’s natural payload with whatever gene they want the soybean to carry, then let the bacterium infect a piece of soybean tissue. Research has shown that the apical meristem of the hypocotyl, the short stem segment just above the root of a seedling, is the primary target tissue where Agrobacterium successfully delivers DNA in soybean.¹ A newer variation of this method, called GiFT (genotype-independent fast transformation), uses germinated seeds as the starting material and involves only a few simple steps, making the process faster and workable across a wider range of soybean varieties.²

The second major delivery method is particle bombardment, sometimes called biolistics or a “gene gun.” In this approach, tiny metal particles, usually gold or tungsten, are coated with the desired DNA and literally shot into plant cells at high speed. For soybean, the target tissue is often an embryogenic culture: masses of cells grown from immature seed tissue that are capable of developing into whole embryos. After bombardment, the cells that take up, incorporate, and express the new DNA are selected using a co-delivered antibiotic resistance gene that lets transformed cells survive on a selective growth medium while untransformed cells die off.³ Particle bombardment has been used in soybean transformation since the early days of the technology, with researchers evaluating it across different regeneration systems.⁴

Each method has strengths. Agrobacterium tends to insert fewer copies of the transgene, which generally means cleaner, more predictable integration into the plant’s chromosomes. Particle bombardment can be more brute-force, sometimes inserting multiple or fragmented copies of the DNA, but it works with tissue types and varieties that may resist Agrobacterium infection. The choice often depends on the soybean genotype and the goals of the project.

What Goes Into the DNA Construct

The gene itself is only one piece of the package that gets inserted. Scientists assemble a “construct,” a custom stretch of DNA that includes several functional parts working together. The best-known example in soybean is the Roundup Ready line 40-3-2, the first commercially approved glyphosate-tolerant soybean. Its single genetic insert contains a version of the cauliflower mosaic virus 35S promoter (which acts like an “on switch” telling the cell to read the gene), a chloroplast transit peptide from petunia (which directs the resulting protein to the right compartment inside the cell), the CP4 EPSPS gene from Agrobacterium sp. strain CP4 (which actually produces the glyphosate-tolerant enzyme), and a terminator sequence from the nopaline synthase gene (which signals the cell to stop reading).⁵

Each element serves a purpose. The promoter controls when and where the gene is active. A strong constitutive promoter like the 35S drives expression in most tissues at most times, while a seed-specific promoter limits activity to the developing seed, which matters when the goal is to change oil composition rather than whole-plant herbicide tolerance. The transit peptide ensures the protein ends up in the chloroplast, where it needs to function. And the terminator wraps up the message cleanly so the cell’s machinery does not read into neighboring DNA. The CP4 EPSPS protein produced by this construct makes the plant tolerant to glyphosate herbicide, the defining trait of Roundup Ready soybeans.⁶

Growing a Whole Plant From a Handful of Transformed Cells

Inserting DNA into a few cells is only half the battle. Those cells need to regenerate into a complete, fertile plant, and soybean is notoriously difficult to regenerate compared to crops like rice or tobacco. The most common starting tissues are cotyledonary nodes (the junction where the seed leaves meet the stem) and hypocotyls. In tissue culture, these explants are coaxed with plant hormones to produce adventitious shoots, tiny new stems that arise from the wounded surface. Among commercial soybean varieties, shoot induction rates from cotyledonary node explants range from about 75 to 100 percent, with each explant producing roughly 2.6 to 10.5 shoots, depending on genotype.⁷

Once shoots form, they are transferred to rooting medium, then gradually moved from sterile lab conditions to a greenhouse. This acclimatization phase is critical; a shoot that thrived under artificial light and humidity can wilt fast in a real-world environment. The regenerated plants are then grown to maturity and allowed to set seed. Only a small fraction of the initial explants produce plants that carry the transgene in every cell, are fertile, and pass the trait on reliably to the next generation. That is why transformation efficiency in soybean remains an active area of research, and why newer methods like GiFT, which simplifies the whole pipeline using germinated seeds instead of tissue-culture explants, have generated excitement.

In one demonstration of the GiFT approach, researchers wounded the cotyledonary node region of germinated soybean seeds, infected them with Agrobacterium, and then placed cotton balls soaked in glyphosate herbicide on the node to select for transformed cells. After two to three weeks, glyphosate-resistant shoots grew from the treated region, showing that transgenic plants could be recovered without the long tissue-culture phase.⁸

Selecting and Confirming Transformed Plants

After regeneration, not every surviving plant actually carries the transgene in a stable, heritable form. Scientists use selectable markers, genes that confer resistance to an antibiotic or herbicide, to weed out untransformed tissue early on. But once the desired transgenic events are identified, those marker genes are often no longer needed and can be a regulatory or public-perception concern. Techniques exist to remove them after the fact. One approach uses the Cre-lox recombination system, where a recombinase enzyme recognizes specific DNA sequences flanking the marker gene and snips it out of the genome.⁹

Molecular verification goes deeper than just checking whether the plant survives on selective medium. Researchers use techniques like Southern blotting and quantitative real-time PCR to determine how many copies of the transgene inserted and where they landed. For example, in a study engineering soybeans to produce beta-carotene, Southern blotting confirmed that each transgenic line contained multiple insertion events, and qRT-PCR provided further estimates of T-DNA integration.¹⁰ More recently, whole-genome sequencing has entered the verification toolkit. In an analysis of the GM soybean event FG72, paired-end whole-genome sequencing revealed two tandem repeats of the T-DNA inserted at a specific genomic site, a finding that was confirmed by digital droplet PCR.¹¹ This level of scrutiny matters for regulatory approval, where authorities want to know exactly what is in the genome and where it sits.

Beyond Herbicide Tolerance

Glyphosate tolerance dominates the GM soybean landscape, but it is far from the only trait that has been engineered. Insect resistance using genes from the bacterium Bacillus thuringiensis (Bt) has been developed for soybean to control major caterpillar pests.¹² Modern Bt soybean events often stack multiple insecticidal genes. Products combining genes like Cry1Ac, Cry1F, and Cry2Ab alongside herbicide-tolerance genes have been approved and deployed in the field, partly to stay ahead of insect resistance that can develop when only a single Bt protein is used.¹³

Oil quality modification is another major area. Standard soybean oil is high in polyunsaturated fats, which makes it prone to oxidation and limits its use in frying and shelf-stable products. By silencing the gene for delta-12 oleate desaturase (GmFAD2-1B), the enzyme that converts oleic acid into linoleic acid, researchers have dramatically shifted the fatty acid profile. In one line, oleic acid content jumped from about 20 percent to roughly 80 percent while linoleic and linolenic acid dropped correspondingly.¹⁴ Another group using antisense RNA to silence a related desaturase gene achieved oleic acid levels above 50 percent with palmitic acid dropping below 3 percent.¹⁵ The resulting high-oleic soybean oil is more heat-stable and does not require partial hydrogenation, avoiding the creation of trans fats.

An important question with any gene-silencing approach is whether the effect holds over many generations of seed production. Data from one high-oleic, low-palmitic soybean line showed that the RNA interference transgene remained stable for over 15 generations, consistently downregulating the target fatty acid genes and maintaining enhanced oleic acid content in mature seeds.¹⁶ That kind of multi-generational stability is essential for commercialization; a trait that fades after a few breeding cycles would be useless to farmers.

CRISPR and the Shift Toward Gene Editing

The methods described above are “transgenic” in the classical sense: they move DNA from one organism into another. A newer category of tools edits the soybean’s own genome without necessarily leaving foreign DNA behind. Genome editing in soybean started with zinc-finger nucleases (ZFNs) and TALENs, but CRISPR/Cas quickly became the preferred approach because it is more precise, easier to design, and cheaper to implement.¹⁷ These newer tools can knock out a gene, tweak a single DNA letter, or insert a new sequence at a precise location.

One of the promises of CRISPR is that the editing machinery can do its job and then be bred out of the plant in subsequent generations, leaving behind only the intended edit and no foreign DNA. However, inheritance does not always follow the textbook. A study tracking CRISPR/Cas9 transgenes and their induced mutations across soybean generations found some unexpected patterns: in one family the transgene and mutations were not transmitted to progeny at all, in another the transgene inserted at four unlinked locations including two that were themselves CRISPR target break sites, and in a third family the mutations were present and inherited even though the transgene itself showed no evidence of stable integration.¹⁸ These complexities are a reminder that even “precise” editing tools can produce surprises when deployed in a living genome, and careful molecular characterization across generations remains essential.

New plant breeding technologies like CRISPR also carry a potential advantage for public acceptance, since they can produce changes identical to what might arise through natural mutation or conventional breeding, without permanently introducing DNA from another species.¹⁹ Regulatory frameworks are still catching up with this distinction, and different countries treat gene-edited crops very differently from transgenic ones.

Stacking Traits in a Single Plant

Commercial GM soybeans increasingly carry more than one transgene. Trait stacking, the combination of multiple engineered genes in one plant, has been a growing trend in global agriculture. A soybean variety might carry both herbicide tolerance and insect resistance, or tolerance to two different herbicides, giving farmers more flexibility in weed management. But stacking raises questions about whether combining transgenes creates interactions that neither gene would produce alone.

A transcriptomic study comparing single-transgene versus stacked herbicide-resistant soybean varieties after glyphosate application found disturbances in defense and redox homeostasis pathways in the stacked variety that were not observed to the same degree in the single-transgene line.²⁰ Whether these molecular-level changes translate into meaningful differences in field performance or food safety is still debated, but the finding illustrates why regulators often want stacked events assessed independently rather than assuming that if each trait is safe alone, the combination must be safe too.

Safety Assessment and the Concept of Substantial Equivalence

Before any GM soybean reaches the market, it undergoes a safety evaluation anchored in the concept of “substantial equivalence.” The idea is to compare the modified plant to its conventional parent across a wide panel of nutrients, antinutrients, and naturally occurring toxins. In soybean, that panel includes protease inhibitors, lectins, isoflavones, and phytate, all of which are present in conventional soybeans and can vary substantially depending on growing conditions. An analysis of regulatory documents found that concentrations of these inherent toxins and antinutrients in modified soybeans generally fell within the natural range seen in the parental lines, though the review noted that environmental influences on these constituents deserve more attention.²¹

Substantial equivalence is not a declaration that the GM crop is identical to the conventional one. It is a starting point. If a compositional analysis reveals that some compound is outside the normal range, that triggers further investigation into whether the difference is biologically meaningful. Critics argue the concept sets too low a bar; defenders say it provides a structured, science-based framework for flagging potential problems. Either way, it has been the bedrock of GM food safety assessment in most countries for decades.

Gene Flow From GM Soybean to Wild Relatives

Cultivated soybean (Glycine max) can cross with its wild ancestor (Glycine soja) where the two grow in proximity, particularly in East Asia. A field study measured pollen-mediated gene flow from glyphosate-resistant soybean to wild soybean at rates ranging from about 0.29 percent in mixed plantings down to 0.027 percent at eight meters of distance. The researchers estimated that an isolation distance of roughly 38 meters would be needed to reduce gene flow below 0.01 percent.²² That might sound small, but the hybrids showed traits intermediate between the cultivated and wild parents, with seed dormancy and reproductive output closer to the wild type, meaning they could persist in natural settings.

A separate three-year study examined the fitness of hybrids between GM and wild soybean and found that while hybrid seed germination was lower than GM soybean, seed productivity was higher, and both traits resembled wild soybean. The EPSPS transgene was stably expressed in positive hybrid plants, yet its presence did not appear to change the plant’s vigor compared to transgene-negative siblings. The researchers noted that hybridization itself, not just the transgene, may confer a competitive benefit through increased biomass and yield.²³ This matters most in regions of soybean’s genetic origin in East Asia, where wild populations exist. In the Americas, where most GM soybean is grown, there are no wild Glycine soja populations for the crop to cross with, so pollen-mediated gene flow is not a practical concern.

Regulatory Differences Across Countries

How GM soybean is regulated varies enormously by jurisdiction. The United States evaluates GM crops through a coordinated framework involving the USDA, EPA, and FDA, with substantial equivalence as a key guiding principle. The European Union applies a precautionary approach, requiring pre-market authorization with extensive case-by-case risk assessment. Many South American countries, particularly Brazil and Argentina, which are among the world’s largest soybean producers, have approved multiple GM soybean events. Yet asynchronous regulatory approval, where one country has approved an event that another has not, can create real trade disruptions. Gravity-model analysis has shown that these asynchronous timelines negatively affect trade flows of soybeans, with countries that have comprehensive GMO import frameworks feeling the impact more acutely.²⁴

The regulatory picture for gene-edited soybeans is even more unsettled. In the United States, if a CRISPR edit could have occurred through conventional breeding and no foreign DNA remains in the final plant, the product may not fall under the same regulatory requirements as a traditional transgenic crop. Argentina adopted a similar “process-based versus product-based” determination early on. The EU, by contrast, ruled in 2018 that gene-edited organisms fall under its existing GMO directive, effectively subjecting them to the same stringent approval process as transgenic crops. These policy divergences mean that a high-oleic soybean created by CRISPR knockout of a desaturase gene might be sold freely in one country and face years of regulatory review in another, even though the resulting plant is chemically identical.

Marker-Free and Novel Delivery Systems

A persistent technical goal in soybean transformation is eliminating selectable marker genes from the final product. Beyond the Cre-lox system mentioned earlier, researchers are exploring entirely different delivery organisms. One group demonstrated gene targeting in soybean using Ochrobactrum haywardense, a bacterium distinct from Agrobacterium, to deliver a construct containing a CRISPR guide RNA, a Cas9 expression cassette, a color marker, and a hygromycin-resistance gene flanked by homology arms for precise integration. After transient Cas9 expression, the donor DNA was released and incorporated at the intended genomic site.²⁵ The use of a visual color marker like DsRED instead of an antibiotic-resistance gene is appealing because it lets researchers screen transformed cells under fluorescence without relying on chemical selection, and the marker can then be segregated away in subsequent generations.

These advances reflect an ongoing effort to make the final product as “clean” as possible: ideally, a soybean plant that carries only the intended genetic change, with no residual marker genes, no bacterial backbone DNA, and no off-target insertions. Whether the public will perceive such a plant differently from a first-generation transgenic soybean is an open question, but the technical capacity to produce it is growing rapidly.